{
    "organizations": [],
    "uuid": "303d660f2a14a7bfb0eab67b46c63501f2d553f4",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-xvivo-perfusion-q1-adjusted-ebitda/brief-xvivo-perfusion-q1-adjusted-ebitda-sek-7-2-million-idUSFWN1S21GQ",
    "ord_in_thread": 0,
    "title": "Xvivo Perfusion Q1 Adjusted. EBITDA Sek 7.2 Million",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 26 (Reuters) - Xvivo Perfusion AB:\n* Q1 ADJUSTED. EBITDA SEK 7.2 MILLION VERSUS SEK 5.0 MILLION YEAR AGO\n* Q1 NET SALES SEK 42.5 MILLION VERSUS SEK 37.5 MILLION YEAR AGO Source text for Eikon: (Gdynia Newsroom)\n ",
    "published": "2018-04-26T13:10:00.000+03:00",
    "crawled": "2018-04-27T16:25:48.021+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "xvivo",
        "perfusion",
        "ab",
        "q1",
        "adjusted",
        "ebitda",
        "sek",
        "million",
        "versus",
        "sek",
        "million",
        "year",
        "ago",
        "q1",
        "net",
        "sale",
        "sek",
        "million",
        "versus",
        "sek",
        "million",
        "year",
        "ago",
        "source",
        "text",
        "eikon",
        "gdynia",
        "newsroom"
    ]
}